Efficacy and adverse reaction of Escitalopram in treatment of 40 patients with primary insomnia
-
摘要: 目的 使用艾司西酞普兰治疗原发性失眠症,研究艾司西酞普兰对患者的睡眠的改善情况以及在治疗过程中对患者造成的不良反应情况。 方法 选择2014年6月—2015年6月接受治疗的80例睡眠有障碍的患者作为研究对象,在研究初期将80例患者随机分为观察组和对照组,每组各40例。观察组采用草酸艾司西酞普兰片的初始剂量为5 mg/d,在早饭之后服用,根据患者病情的加重逐步增到20 mg/d,唑吡坦片初始剂量为5~10 mg/d,睡前服用,疗程为8周。对照组仅采用唑吡坦片初始剂量为5~10 mg/d,睡前服用,疗程为8周。观察2组患者治疗前与治疗后第1周末、第4周末、第8周末的匹兹堡睡眠质量指数量表(PSQI)、患者健康问卷抑郁量表(PHQ-9)的指标变化以及不良反应情况,使用SPSS 18.0统计软件进行数据分析。 结果 2组患者治疗后第1周末、第4周末、第8周末的PSQI总分与治疗前比较,均有下降(P<0.05)。在第8周末,观察组患者的PSQI总分比对照组低(P<0.05)。2组患者治疗后第1周末、第4周末、第8周末的PHQ-9总分与治疗前比较,均有下降(P<0.05)。在第8周末,观察组患者的PHQ-9总分比对照组低(P<0.05)。2组患者在治疗过程中出现的不良反应都不严重,观察组患者的不良反应发生率是32.5%,对照组为27.5%,2组比较差异无统计学意义(P>0.05)。 结论 通过艾司西酞普兰治疗原发性失眠,患者的睡眠得到有效改善,但是震颤、便秘等不良反应发生率较高,医护人员要高度重视。Abstract: Objective To study the efficacy and adverse reaction of Escitalopram in the treatment of primary insomnia. Methods Total 80 patients with sleep disorders in our hospital between June,2014 and June,2015 were enrolled and randomly divided into observation group and control group with 40 cases in each group.The observation group was given Escitalopram Oxalatetablets [After breakfast,oral,initial dose of 5 mg/d,gradually increased to 20 mg/d] and Zolpidem tablet[at bedtime,oral,initial dose of 5 to 10 mg/d] for 8 weeks,while the control group was given Zolpidem tablets [at bedtime,oral,initial doseof 5 to 10 mg/d] for 8 weeks.Before the treatment and 1,4 and 8 weeks after the treatment,Pittsburgh sleep quality index(PSQI) scale,patient health questionnaire (PHQ-9) index were measured,and the incidence of adverse reactions was observed.SPSS 18.0 was used to analyze the data. Results PAQI total score on the 1st,4th and 8th weekend after the treatment decreased in both groups,P<0.05.On the 8th weekend,the total scores of PSQI in the observation group were significantly lower than that in the control group,P<0.05.PHQ-9 total scoreon the 1st,4th and 8th weekend after the treatment decreased in both groups,P<0.05.On the 8th weekend,the total scores of PHQ-9 in the observation group were significantly lower than that in the control group,P<0.05.The mild adverse reactions were found in both groups.The incidence of adverse reactions in the observation group was 32.5%,and in the control group was 27.5%,the difference was not statistically significant,P>0.05. Conclusion Escitalopram can effectively improve the sleep quality in patients with primary insomnia,but the incidence of adverse reactions such as tremor and constipationis relatively high,which should be paid more attentions.
-
Key words:
- Escitalopram Oxalate /
- Zolpidem tablet /
- Primary insomnia /
- Curative effect /
- Adverse reactions
点击查看大图
计量
- 文章访问数: 159
- HTML全文浏览量: 19
- PDF下载量: 1
- 被引次数: 0